» Articles » PMID: 33807943

Manganese Ferrite Nanoparticles Enhance the Sensitivity of Hepa1-6 Hepatocellular Carcinoma to Radiation by Remodeling Tumor Microenvironments

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Apr 3
PMID 33807943
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

We evaluated the effect of manganese ferrite nanoparticles (MFN) on radiosensitization and immunologic responses using the murine hepatoma cell line Hepa1-6 and the syngeneic mouse model. The clonogenic survival of Hepa1-6 cells was increased by hypoxia, while being restricted by ionizing radiation (IR) and/or MFN. Although MFN suppressed HIF-1α under hypoxia, the combination of IR and MFN enhanced apoptosis and DNA damage in Hepa1-6 cells. In the Hepa1-6 syngeneic mouse model, the combination of IR and MFN notably limited the tumor growth compared to the single treatment with IR or MFN, and also triggered more frequent apoptosis in tumor tissues than that observed under other conditions. Increased expression of PD-L1 after IR was not observed with MFN alone or the combination of IR and MFN in vitro and in vivo, and the percentage of tumor-infiltrating T cells and cytotoxic T cells increased with MFN, regardless of IR, in the Hepa1-6 syngeneic mouse model, while IR alone led to T cell depletion. MFN might have the potential to overcome radioresistance by alleviating hypoxia and strengthening antitumor immunity in the tumor microenvironment.

Citing Articles

Prospects of nanoparticle-based radioenhancement for radiotherapy.

Gerken L, Gerdes M, Pruschy M, Herrmann I Mater Horiz. 2023; 10(10):4059-4082.

PMID: 37555747 PMC: 10544071. DOI: 10.1039/d3mh00265a.


Abrine, an IDO1 inhibitor, suppresses the immune escape and enhances the immunotherapy of anti-PD-1 antibody in hepatocellular carcinoma.

Liang X, Gao H, Xiao J, Han S, He J, Yuan R Front Immunol. 2023; 14:1185985.

PMID: 37334368 PMC: 10272936. DOI: 10.3389/fimmu.2023.1185985.


The role of hypoxia-inducible factor 1 alpha (HIF-1α) modulation in heavy metal toxicity.

Aschner M, Skalny A, Lu R, Santamaria A, Zhou J, Ke T Arch Toxicol. 2023; 97(5):1299-1318.

PMID: 36933023 DOI: 10.1007/s00204-023-03483-7.


Nanoparticle-based radiosensitization strategies for improving radiation therapy.

Shen H, Huang H, Jiang Z Front Pharmacol. 2023; 14:1145551.

PMID: 36873996 PMC: 9977822. DOI: 10.3389/fphar.2023.1145551.


Nanoparticle-Based Radiosensitization.

Kempson I Int J Mol Sci. 2022; 23(9).

PMID: 35563326 PMC: 9102109. DOI: 10.3390/ijms23094936.


References
1.
Lee N, Choi Y, Lee Y, Park M, Moon W, Choi S . Water-dispersible ferrimagnetic iron oxide nanocubes with extremely high r₂ relaxivity for highly sensitive in vivo MRI of tumors. Nano Lett. 2012; 12(6):3127-31. DOI: 10.1021/nl3010308. View

2.
Kanagesan S, Aziz S, Hashim M, Ismail I, Tamilselvan S, Alitheen N . Synthesis, Characterization and in Vitro Evaluation of Manganese Ferrite (MnFe2O4) Nanoparticles for Their Biocompatibility with Murine Breast Cancer Cells (4T1). Molecules. 2016; 21(3):312. PMC: 6273739. DOI: 10.3390/molecules21030312. View

3.
Noman M, Desantis G, Janji B, Hasmim M, Karray S, Dessen P . PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation. J Exp Med. 2014; 211(5):781-90. PMC: 4010891. DOI: 10.1084/jem.20131916. View

4.
Overgaard J . Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck--a systematic review and meta-analysis. Radiother Oncol. 2011; 100(1):22-32. DOI: 10.1016/j.radonc.2011.03.004. View

5.
Mondini M, Levy A, Meziani L, Milliat F, Deutsch E . Radiotherapy-immunotherapy combinations - perspectives and challenges. Mol Oncol. 2020; 14(7):1529-1537. PMC: 7332212. DOI: 10.1002/1878-0261.12658. View